[A version of this item appears in: Dementia and Elderly Care: the Latest Evidence Newsletter (RWHT), Volume 3 Issue 3, October 2012].
NICE has produced a series of academic detailing aids (ADAs) from “NPC Key Therapeutic Topics: medicines management options for local implementation”. These ADAs are intended to support discussions about key prescribing and medicines optimisation. Academic detailing is thought to improve clinical decision-making, reduce inappropriate prescribing and minimise unnecessary expenditure on healthcare (Soumerai and Avorn (1990), National Audit Office (2007)).
One of these ADAs covers low dose antipsychotics in people with dementia.
Note: This resource is not a NICE guideline and does not supersede or replace any NICE guidance.
NICE (2012). Support for education and learning: academic detailing aid. Low dose antipsychotics in people with dementia. London: National Institute for Health and Clinical Excellence (NICE), March / September 2012.